Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brimonidine Tartrate in Open-Angle Glaucoma or Ocular Hypertension
NCT00061529Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jan 2003
- Primary completion
- Jul 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of brimonidine in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Jan 2003; status: completed.
02
Drugs
brimonidine
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00061529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00061529.